Staburo took part in the BVMA symposium on 25 November 2022, at the Westin Grand Hotel, here in Munich. This year it was the 30. BVMA symposium and for this anniversary the get-together took place the evening before at the SEA LIFE aquarium in Munich.
Staburo’s Managing Director Roland Stieger joined the BIO-Europe last week and enjoyed the great networking opportunities of this partnering conference with approx. 4800 delegates!
In addition to several one-on-one meetings, in which Roland discussed data science challenges of potential partners, there were panel discussions, e.g. about changes in Health Technology Assessment in Europe with Florian Diwischek (Novartis) and Fabian Berkemeier (IGES).
The gold standard for evaluating medical interventions is a randomised clinical trial with statistical analysis based on the intention-to-treat population. However, even if a randomised clinical trial is well planned, post-randomisation events occur and affect or even challenge the interpretation and validity of the study results.
Nine Staburo colleagues recently took part in a full-day first aid course that was organized in collaboration with the company Springer Medicine publishing, who is a neighbor company in our Munich office building.
Two posters by Staburo members were presented at the PSI 2022 conference in Gothenburg, Sweden. The conference, regarded as the principal annual event of the statisticians in the pharmaceutical industry, took place as face-to-face event from 12th to 15th of June in the Gothia Towers.
The TUM career day panel with the topic leadership was supported by Josef Höfler and other panelists (i.e., Susanne Keller from Baxter, Niklas Grünbauer from TenneT TSO, Bernd Kohler from Takeda and Herbert Reiter from financial.com)
Staburo statisticians joined the DAGStat conference 2022 in Hamburg, March 28 to April 1, hosted at the University Medical Center Hamburg-Eppendorf.
The event was aimed at students with an interest in the field of Medical Statistics, for example within pharmaceuticals, healthcare and/or medical research.
On November 26, Staburo participated in the annual workshop of the APF (working group Pharmaceutical Research) by the International Biometric Society German Region.
Susanne Steinhauser from Staburo GmbH presented the working life of a biostatistician at the ‘Mathematik im Beruf’ series at the University of Konstanz. The series of lectures aim to introduce possible future working fields to students and PhD students of the mathematical faculty.
The gold standard for evaluating medical interventions is a randomised clinical trial with statistical analysis based on the intention-to-treat population. However, even if a randomised clinical trial is well planned, post-randomisation events occur and affect or even challenge the interpretation and validity of the study results.
Staburo Academy online course “Machine learning and high-dimensional methods”
Our course “Machine learning and high-dimensional methods” will be a 2-day course from 07 to 08 June 2021!